Literature DB >> 15207310

Other viral bioweapons: Ebola and Marburg hemorrhagic fever.

Michelle R Salvaggio1, John W Baddley.   

Abstract

The term viral hemorrhagic fever refers to a clinical syndrome characterized by acute onset of fever accompanied by nonspecific findings of malaise, prostration, diarrhea,and headache. Patients frequently show signs of increased vascular permeability, and many develop bleeding diatheses. The hemorrhagic fever viruses represent potential agents for biologic warfare because of capability of aerosol transmission, high morbidity,and mortality associated with infection, and ability to replicate in cell culture in high concentrations. Herein we discuss the Filoviridae, the agents of Ebola and Marburg hemorrhagic fevers.

Entities:  

Mesh:

Year:  2004        PMID: 15207310     DOI: 10.1016/j.det.2004.03.003

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  8 in total

1.  Dengue hemorrhagic fever-associated immunomediators induced via maturation of dengue virus nonstructural 4B protein in monocytes modulate endothelial cell adhesion molecules and human microvascular endothelial cells permeability.

Authors:  James F Kelley; Pakieli H Kaufusi; Vivek R Nerurkar
Journal:  Virology       Date:  2011-11-29       Impact factor: 3.616

2.  Molecular dynamics exploration of the binding mechanism and properties of single-walled carbon nanotube to WT and mutant VP35 FBP region of Ebola virus.

Authors:  Yan-Jun Zhang; Jing-Na Ding; Hui Zhong; Chang-Ping Sun; Ju-Guang Han
Journal:  J Biol Phys       Date:  2017-01-21       Impact factor: 1.365

3.  The structure of the C-terminal domain of the Zaire ebolavirus nucleoprotein.

Authors:  Paulina J Dziubańska; Urszula Derewenda; Jeffrey F Ellena; Daniel A Engel; Zygmunt S Derewenda
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-08-29

4.  Ebola virus epidemic: a deliberate accident?

Authors:  Styliani Loukatou; Paraskevas Fakourelis; Louis Papageorgiou; Vasileios Megalooikonomou; Sophia Kossida; Dimitrios Vlachakis
Journal:  J Mol Biochem       Date:  2014

5.  A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals.

Authors:  Lijuan Yang; Anthony Sanchez; Jerrold M Ward; Brian R Murphy; Peter L Collins; Alexander Bukreyev
Journal:  Virology       Date:  2008-08-01       Impact factor: 3.616

Review 6.  Viral hemorrhagic fevers: current status of endemic disease and strategies for control.

Authors:  Dennis J Cleri; Anthony J Ricketti; Richard B Porwancher; Luz S Ramos-Bonner; John R Vernaleo
Journal:  Infect Dis Clin North Am       Date:  2006-06       Impact factor: 5.982

7.  Combination therapy protects macaques against advanced Marburg virus disease.

Authors:  Robert W Cross; Zachary A Bornholdt; Abhishek N Prasad; Viktoriya Borisevich; Krystle N Agans; Daniel J Deer; Dafna M Abelson; Do H Kim; William S Shestowsky; Lioudmila A Campbell; Elaine Bunyan; Joan B Geisbert; Karla A Fenton; Larry Zeitlin; Danielle P Porter; Thomas W Geisbert
Journal:  Nat Commun       Date:  2021-03-25       Impact factor: 14.919

8.  Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease.

Authors:  Robert W Cross; Zachary A Bornholdt; Abhishek N Prasad; Courtney Woolsey; Viktoriya Borisevich; Krystle N Agans; Daniel J Deer; Dafna M Abelson; Do H Kim; William S Shestowsky; Lioudmila A Campbell; Elaine Bunyan; Joan B Geisbert; Natalie S Dobias; Karla A Fenton; Danielle P Porter; Larry Zeitlin; Thomas W Geisbert
Journal:  JCI Insight       Date:  2022-05-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.